Mojarad-Jabali, S., & Molavipordanjani, S. Lead-212 Radiopharmaceuticals for Receptor-Targeted Radionuclide Therapy. Mazandaran University of Medical Sciences.
Chicago Style (17th ed.) CitationMojarad-Jabali, Solmaz, and Sajjad Molavipordanjani. Lead-212 Radiopharmaceuticals for Receptor-Targeted Radionuclide Therapy. Mazandaran University of Medical Sciences.
MLA (9th ed.) CitationMojarad-Jabali, Solmaz, and Sajjad Molavipordanjani. Lead-212 Radiopharmaceuticals for Receptor-Targeted Radionuclide Therapy. Mazandaran University of Medical Sciences.
Warning: These citations may not always be 100% accurate.